Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Ipsen
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
irosustat
(BN 83495) / Ipsen
botulinum toxin A longer acting
(IPN10200) / Ipsen
mesdopetam
(IRL790) / Ipsen
onzigolide
(TBR-760) / Tiburio
pinometostat
(EPZ-5676) / Ipsen
senrebotase
(SXN100323) / Ipsen, AbbVie
BIOD 531
/ Ipsen
istiratumab
(MM-141) / Ipsen
pemrametostat
(GSK3326595) / Ipsen
Lu 177 zalsenertant tetraxetan
(177Lu-IPN01087) / AstraZeneca
clostridium botulinum neurotoxin serotype A recombinant
(IPN59011) / Ipsen
fidrisertib
(IPN60130) / Ipsen
ultra-rapid-acting recombinant human insulin
(BIOD-123) / Ipsen
BN82451
/ Ipsen
Hexalen
(altretamine) / Ipsen, Eisai
VSN16R
/ Ipsen, University College London
ritivixibat
(IPN60250) / Ipsen
